adorable baby smiling with joy

Peds Calc

Pediatric Reference

Omeprazole Side EffectsComprehensive Pediatric Safety Guide

Omeprazole is usually well tolerated. Mild headache, abdominal discomfort, and loose stools are the most common complaints. Chronic therapy carries additional nutritional and infectious risks that require anticipatory guidance.

6 Categories
15 Clinical Sources
Evidence-Based
Back to Omeprazole Overview

Essential Information

1

Call urgently for watery diarrhea with fever or blood—PPIs can predispose to Clostridioides difficile infection

2

Discuss any new supplements or medicines; omeprazole alters absorption of vitamin B12, magnesium, and some drugs

3

Recheck the treatment plan every 2–3 months for chronic users to limit long-term risks

Clinical Overview

Reassess the need for ongoing proton pump inhibitor (PPI) therapy at each visit. Reinforce hydration and nutritional monitoring, and review red-flag symptoms that warrant urgent evaluation.

Side Effect Categories

6 Systems

Gastrointestinal

2 documented effects

Total Sources: 3

Diarrhea / loose stools

Incidence: Common
Onset: Often within the first week
mild
2 sources
Duration

Not specified

Management

Encourage clear fluids and bland foods; use oral rehydration as needed

Monitoring Guidelines

Escalate for watery diarrhea, abdominal cramping, or fever lasting >24 hours

2 clinical sources• PubMed • Clinical Guidelines • FDA

Abdominal pain / nausea

Incidence: Common
Onset: Not specified
mild
1 sources
Duration

Not specified

Management

Give with meals if discomfort persists; consider evening dosing

Monitoring Guidelines

Evaluate if pain worsens or vomiting limits intake

1 clinical sources• PubMed • Clinical Guidelines • FDA

Neurologic

1 documented effect

Total Sources: 2

Headache or dizziness

Incidence: Common
Onset: Not specified
mild
2 sources
Duration

Not specified

Management

Hydration, rest, over-the-counter analgesics if approved

Monitoring Guidelines

Assess if headaches are persistent, severe, or associated with neurologic deficits

2 clinical sources• PubMed • Clinical Guidelines • FDA

Infectious

2 documented effects

Total Sources: 3

Clostridioides difficile–associated diarrhea

Incidence: Rare
Onset: During therapy or up to several months after
severe
2 sources
Duration

Not specified

Management

Stop omeprazole; arrange same-day evaluation for stool testing and targeted antibiotics

Monitoring Guidelines

Watch for watery or bloody diarrhea, fever, abdominal tenderness

2 clinical sources• PubMed • Clinical Guidelines • FDA

Respiratory infections (upper/lower)

Incidence: Uncommon
Onset: Weeks to months
mild
1 sources
Duration

Not specified

Management

Supportive care; counsel on hand hygiene and symptom monitoring

Monitoring Guidelines

Escalate if recurrent or severe infections develop

1 clinical sources• PubMed • Clinical Guidelines • FDA

Metabolic / nutrient

3 documented effects

Total Sources: 4

Hypomagnesemia (long-term use)

Incidence: Rare
Onset: Usually after ≥3 months of continuous therapy
moderate
2 sources
Duration

Not specified

Management

Check serum magnesium if fatigue, tremors, or arrhythmias appear; supplement or switch therapy

Monitoring Guidelines

Watch for muscle cramps, palpitations, or seizures

2 clinical sources• PubMed • Clinical Guidelines • FDA

Vitamin B12 deficiency

Incidence: Uncommon
Onset: >1 year of continuous therapy
moderate
1 sources
Duration

Not specified

Management

Assess dietary intake, consider measuring B12 levels; supplement if low

Monitoring Guidelines

Monitor for fatigue, neuropathy, glossitis, or anemia

1 clinical sources• PubMed • Clinical Guidelines • FDA

Iron absorption reduction

Incidence: Rare
Onset: Months to years
mild
1 sources
Duration

Not specified

Management

Monitor iron status in children with chronic anemia; coordinate dosing away from iron supplements when feasible

Monitoring Guidelines

Watch for pallor, decreased exercise tolerance

1 clinical sources• PubMed • Clinical Guidelines • FDA

Musculoskeletal

1 documented effect

Total Sources: 1

Bone fracture risk (hip, wrist, spine)

Incidence: Rare
Onset: After ≥1 year of high-dose therapy
moderate
1 sources
Duration

Not specified

Management

Ensure adequate calcium/vitamin D intake, encourage weight-bearing activity, consider rheumatology/endocrinology consult in high-risk teens

Monitoring Guidelines

Assess fracture history, growth, and nutrition during long-term follow-up

1 clinical sources• PubMed • Clinical Guidelines • FDA

Renal / hypersensitivity

2 documented effects

Total Sources: 2

Acute interstitial nephritis

Incidence: Rare
Onset: Any time during therapy
severe
1 sources
Duration

Not specified

Management

Discontinue immediately; arrange urgent evaluation with renal labs and nephrology consult

Monitoring Guidelines

Watch for sudden fatigue, flank pain, hematuria, or decreased urine output

1 clinical sources• PubMed • Clinical Guidelines • FDA

Hypersensitivity reactions (rash, anaphylaxis)

Incidence: Rare
Onset: Any time
severe
1 sources
Duration

Not specified

Management

Stop therapy; use emergency services for airway symptoms; document cross-reactivity with other PPIs

Monitoring Guidelines

Assess for urticaria, angioedema, or respiratory compromise

1 clinical sources• PubMed • Clinical Guidelines • FDA

Parent Communication Guide

Age-Appropriate Explanations

Infants (0-12 months)

For babies taking Omeprazole, watch for signs of side effects. This medication is generally well-tolerated in infants when used as directed.

Toddlers (1-3 years)

This medicine calms tummy acid. Call us if there is watery poop or if they look very tired or puffy.

Children (4-12 years)

Tell us about stomach pain, headaches, loose stools, or new medicines while you are taking omeprazole.

Adolescents (13+ years)

Track symptoms in a diary and report diarrhea, muscle cramps, or supplements you start. Do not stop or double doses without guidance.

Common Parent Concerns

Q: Loose stools after starting

A: This often settles within a few days. Keep fluids up and call if stools become watery, bloody, or are paired with fever or abdominal pain.

When to validate: Urgent evaluation for suspected C. difficile infection

Q: Need for long-term therapy

A: We reassess every few months and use the lowest effective dose. We may monitor magnesium or B12 if therapy continues for many months.

When to validate: Schedule follow-up every 2–3 months

Q: Bone or nutrient health

A: Encourage calcium- and vitamin D–rich foods, weight-bearing activity, and regular follow-up if therapy exceeds a year.

When to validate: Coordinate nutrition visit for high-risk patients

Clinical Decision Support

Severity Assessment Framework

Tiered response to omeprazole adverse effects

Mild
Indicators: Intermittent loose stools, Mild headaches, Transient nausea
Action: Supportive care, reinforce hydration and dosing with meals
Moderate
Indicators: Persistent diarrhea, Muscle cramps, Recurrent respiratory infections
Action: Order targeted labs (electrolytes, magnesium), review duration of therapy, consider dose reduction
Severe
Indicators: Watery diarrhea with fever, Signs of anaphylaxis, Acute kidney injury
Action: Discontinue omeprazole, initiate urgent workup, consider hospital evaluation

Treatment Decision Guidelines

Immediate Discontinuation

    Consider Alternatives

      Dose Modification

        Clinical References

        Omeprazole — FDA DailyMedU.S. National Library of Medicine (2025)Label
        Omeprazole — MedlinePlus Drug InformationMedlinePlus / NIH (2025)Database
        FDA Drug Safety Communication: Possible increased risk of fractures with high-dose PPI therapyU.S. Food and Drug Administration (2010)Safety Communication

        Frequently Asked Questions

        Parent and clinician concerns about Omeprazole